Hepatocyte-specific contrast media for CT: An experimental investigation

Acta Radiologica, Supplement

Volumn 38, Issue 411, 1997, Pages 7-27

  Bergman, Antonina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IODINATED POPPYSEED OIL; LIPID EMULSION; NRI 757;

ANIMAL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; HUMAN; LIVER; LIVER DISEASE; METHODOLOGY; PATHOLOGY; RADIOGRAPHY;

ANIMALS; CHOLESTEROL; CONTRAST MEDIA; FAT EMULSIONS, INTRAVENOUS; HUMANS; IODIZED OIL; LIVER; LIVER DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030627558     PISSN: 03655954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (172)

1. ADAM G., GüNTHER R., SCHIFFER C., GöRTZ H., PRESCHER A. & SCHERER K.: Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model. Invest. Radiol. 27 (1992), 698.
2. ADSON M.: Hepatic metastases in perspective. AJR 140 (1983), 695.
3. ALPERN M., LAWSON T., FOLEY W. et al.: Focal hepatic masses and fatty infiltration detected by enhanced dynamic CT. Radiology 158 (1986), 45.
4. ALPERS D. & SABESIN S.: Fatty liver. Biochemical and clinical aspects. In: Diseases of the liver, p. 949. Edited by L. Schiff & E. Schiff. J. B. Lippincott Co., Philadelphia 1987.
5. ARCHER R.: Haematological techniques for use on animals. Blackwell Scientific, Oxford 1965.
6. BAKER M. & PELLEY R.: Hepatic metastases. Basic principles and implications for radiologists. Radiology 197 (1995), 329.
7. BARON R.: Detection of liver neoplasms. Techniques and outcomes. Abdom. Imaging 19 (1994), 320.
8. BARON R.: Understanding and optimizing use of contrast material for CT of the liver. AJR 163 (1994), 323.
9. BARTOLOZZI C., LENCIONI R., CARAMELLA D., PALLA A., BASSI A. & DI CANDIO G.: Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT. Acta Radiol. 37 (1996), 69.
10. BEHAN M., O'CONNELL D., MATTREY R. F. & CARNEY D. N.: Perfluorooctylbromide as a contrast agent for CT and sonography. Preliminary clinical results. AJR 160 (1993), 399.
11. BENNETT W. & BOVA J.: Review of hepatic imaging and a problem-oriented approach to liver masses. Hepatology 12 (1990), 761.
12. BERNARDINO M. E., ERWIN B. C., STEINBERG H. V., BAUMGARTNER B. R., TORRES W. E. & GEDGAUDAS-MCCLEES R. K.: Delayed hepatic CT scanning. Increased confidence and improved detection of hepatic metastases. Radiology 159 (1986), 71.
13. BLUEMKE D. & FISHMAN E.: Spiral CT of the liver. AJR 160 (1993), 787.
14. BLUEMKE D., SOYER P. & FISHMAN E.: Helical (spiral) CT of the liver. Radiol. Clin. North Am. 33 (1995), p. 863.
15. BLUEMKE D., SOYER P. & FISHMAN E.: Nontumorous low-attenuation defects in the liver on helical CT during arterial portography. Frequency, location, and appearance. AJR 164 (1995), 1141.
16. BLUEMKE D. A., URBAN B. & FISHMAN E. K.: Spiral CT of the liver. Current applications. Semin. Ultrasound CT MR 15 (1994), 107.
17. BONALDI V M., BRET P. M., REINHOLD C. & ATRI M.: Helical CT of the liver. Value of an early hepatic arterial phase. Radiology 197 (1995), 357.
18. BOSWELL W: Contrast agents in helical CT. In: 7th Nord. Course Comput. Tomogr. MR, p. 41. Department of Diagnostic Radiology, Uppsala 1996.
19. BOYLE P., ZARIDZE D. & SMANS M.: Descriptive epidemiology of colorectal cancer. Int. J. Cancer 36 (1985), 9.
20. BREEN K., SCHENKER S. & HEIMBERG M.: Fatty liver induced by tetracycline in the rat. Gastroenterology 69 (1975), 714.
21. BRINK J., HEIKEN J., FORMAN H., SAGEL S., MOLINA P. & BROWN P.: Hepatic spiral CT. Reduction of dose of intravenous contrast material. Radiology 197 (1995), 83.
22. BRUNETON J. N., FALEWEE M. N., FRANCOIS E. et al.: Liver, spleen, and vessels. Preliminary clinical results of CT with perfluorooctylbromide. Radiology 170 (1989), 179.
23. BURGENER F. & HAMLIN D.: Contrast enhancement in abdominal CT. Bolus vs. infusion. AJR 137 (1981), 351.
24. BURGENER F. & HAMLIN D.: Contrast enhancement of hepatic tumors in CT. Comparison between bolus and infusion techniques. AJR 140 (1983), 291.
25. CHAMBERS T. P., BARON R. L. & LUSH R. M.: Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients. Radiology 193 (1994), 513.
26. CHAMBERS T. P., BARON R. L. & LUSH R. M.: Hepatic CT enhancement. Part II. Alterations in contrast material volume and rate of injection within the same patients. Radiology 193 (1994), 518.
27. CHEN M. C-M., TSANG Y.-M., STARK D. et al.: Hepatic metastases. Rat models for imaging research. Magn. Reson. Imaging 7 (1989), 1.
28. CHENG K. T. & SELTZER S. E.: Liposome-encapsulated contrast agents in diagnostic imaging. In: Contrast media. Biologic effects and clinical application, p. 73. Edited by Z. Parvez, R. Montana and M. Sovak, CRC Press, Boca Raton 1987.
29. CHENG M.-M., TSANG Y.-M., STARK D. et al.: Hepatic metastases. Rat models for imaging research. Magn. Reson. Imaging 7 (1989), 1.
30. CHEZMAR J., BERNARDINO M., KAUFMAN S. & NELSON R.: Combined CT arterial portography and hepatic angiography for evaluation of the hepatic resection candidate. Work in progress. Radiology 189 (1993), 407.
31. Cox I. H., FOLEY W. D. & HUFFMAN R. G.: Right window for hepatic CT. Radiology 181 (1991), 18.
32. DEAN P., VIOLANTE M. & MAHONEY J.: Hepatic CT contrast enhancement. Effect of dose, duration of infusion, and time elapsed following infusion. Invest. Radiol. 15 (1980), 158.
33. ELIZONDO G., WEISSLEDER R., STARK D. et al.: Hepatic cirrhosis and hepatitis. MR imaging enhanced with superparamagnetic iron oxide. Radiology 174 (1990), 797.
34. ENBLAD P., ADAMI H.-O., BERGSTRÖM R., GLIMELIUS B., KRUSEMO U. & PÅHLMAN L.: Improved survival of patients with cancers of the colon and rectum. J. Ntl. Cancer Inst. 80 (1988), 586.
35. FARBER E., SIMPSON M. & TRAVER H.: Studies on ethionine II. The interference with lipid metabolism. J. Biol. Chem. 182 (1950), 91.
36. FARRELL L., WRIGHT T., LAKE J., ROBERSTS J. & ASCHER N.: Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology 16 (1992), 1372.
37. FERRUCI J.: Liver tumor imaging. Current concepts. Keio J. Med. 40 (1991), 194.
38. FLETCHER M.: A colorimetric method for estimating serum triglycerides. Clin. Chim. Acta 22 (1968), 393.
39. FLOCH J., LEES M. & STANLEY G.: A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226 (1957), 497.
40. FOLEY W: Dynamic hepatic CT scanning. AJR 152 (1989), 272.
41. FOLEY W., HOFFMANN R., QUIROZ F., KAHN C. & PERRET R.: Hepatic helical CT. Contrast material injection protocol. Radiology 192 (1994), 367.
42. FOLEY W. D.: Dynamic hepatic CT. Radiology 170 (1989), 617.
43. FREENY P.: Hepatic CT. State of art. Radiology 168 (1988), 319.
44. FREENY P., GARDNER J., VON INGERSLEBEN G., HEYANO S., NGHIEM H. & WINTER T: Hepatic helical CT. Effect of reduction of iodine dose of intravenous contrast material on hepatic contrast enhancement. Radiology 197 (1995), 89.
45. FREENY P., NGHIEM H. & WINTER T: Helical CT during arterial portography. Optimization of contrast enhancement and scanning parameters. Radiology 194 (1995), 83.
46. FRUMAN S., HARNED R. II, MARCUS D., KAUFMAN S., SWENSON R. & BERNARDINO M.: Perfluoroctyl bromide as a blood pool contrast agent for computed tomographic angiography. Acad. Radiol. 1 (1994), 151.
47. GAZELLE S., WOLF G., BACON E., MCINTIRE G., COOPER E. & TONER J.: Nanocrystalline computed tomography contrast agents for blood-pool and liver-spleen imaging. Invest. Radiol. 29 (1994), S286.
48. GAZELLE S., WOLF G., MCINTIRE G. et al.: Hepatic imaging with iodinated nanoparticles. A comparison with iohexol in rabbbits. Acad. Radiol. 2 (1995), 700.
49. GIOVANELLA B., STEHLIN J. & COIL D: Human tumors heterotransplanted in nude mouse and rats. A comparative study. Expl. Cell Biol. 52 (1984), 76.
50. GIØEN T, HOLTZ E., STRANDE P., KLAVENESS J., LEANDER P. & BERG A.: Particulate biodegradable contrast medium for CT of the liver, p. 394. Andover Medical Publications, Boston 1990.
51. GLAZER G., LONGINO M., SCHWENDNER S., COUNSELL R. & WEICHERT J.: Lipid soluble contrast agents for computed tomography of the liver. Results with cholesteryl iopanoate. J. Comput. Assist. Tomogr. 7 (1983), 775.
52. GORES G.: Liver transplantation for malignant disease. Gastroenterol. Clin. North Am. 22 (1993), 285.
53. GRAF W., SUNDIN A., GLIMELIUS B., AHLSTRÖM H. & CARLSSON J.: Induction and quantification of hepatic metastases from a human colonic cancer in the nude rat. Eur. J. Surg. Oncol. 18 (1992), 608.
54. GROSS J., REICHEN J., ZELTNER T. & ZIMMERMANN A.: The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis. Correlation with morphometric measurement of hepatocyte mass. Hepatology 7 (1978), 457.
55. HALVORSEN R., KOROBKIN M., RAM P. & THOMPSON W.: CT appearance of focal fatty infiltration of the liver. AJR 139 (1982), 277.
56. HANSEN C.: The nude gene and its effects. In: The nude mouse in experimental and clinical research, p. 1. Edited by J. Fogh & B. Giovanella. Academic Press, London 1978.
57. HARNED R. K. II, CHEZMAR J. L. & NELSON R. C.: Imaging of patients with potentially resectable hepatic neoplasms. AJR 159 (1992), 1191.
58. HEIKEN J., BRINK J., MCCLENNAN B., SAGEL S., CROWE T. & GAINES M.: Dynamic incremental CT. Effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 195 (1995), 353.
59. HEIKEN J., BRINK J., MCCLENNAN B., SAGEL S., FORMAN H. & DICROCE J.: Dynamic contrast-enhanced CT of the liver. Comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. Radiology 187 (1993), 327.
60. HEIKEN J. P., WEYMAN P. J., LEE J. K. T. et al.: Detection of focal hepatic masses. Prospective evaluation with CT, delayed CT. CT during arterial portography and MR imaging. Radiology 171 (1989), 47.
61. HEMMINGSSON A., JUNG B., NÄSLUND L. & YTTERBERGH B.-O.: Perceptibility of experimental and clinical lesions in the CT image with and without image processing. Acta Radiol. 22 (1981), 67.
62. HOIGNÉ R.: Penicillins, cephalosporins and tetracyclines. In: An encyclopedia of adverse reactions and interactions, p. 469. Edited by M. Dukes. Elsevier, Amsterdam 1984.
63. HONDA H., OCHIAI K., ADACHI E. et al.: Hepatocellular carcinoma. Correlation of CT, angiographic, and histopathologic findings. Radiology 189 (1993), 857.
64. HOWELL J., FACUNDUS D, KAY D., MATTHEWS C. & WALKER A.: Hepatic tumors. Role of computed tomographic arterial portography in surgical planning. South Med. J. 86 (1993), 1133.
65. HUGHES K., SIMON R., SONGHORABODI S. et al.: Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of patterns of recurrence. Surgery 100 (1986), 278.
66. IKEDA K., SAITOH S., KOIDA I. et al.: Imaging diagnosis of small hepatocellular carcinoma. Hepatology 20 (1994), 82.
67. IRIE T. & KUSANO S.: Contrast-enhanced spiral CT of the liver. Effect of injection time on time to peak hepatic enhancement. J. Comput. Assist. Tomogr. 20 (1996), 633.
68. IRIE T., TAKESHITA K., WADA Y. et al.: CT evaluation of hepatic tumors. Comparison of CT with arterial portography, CT with infusion hepatic arteriography, and simultaneous use of both techniques. AJR 164 (1995), 1407.
69. IRIE T., TSUSHIMA Y., TERAHATA S., HATSUSE K. & KUSANO S.: Influence of liver cirrhosis on pseudolesions in liver at CT during arterial portography. J. Comput. Assist. Tomogr. 20 (1996), 914.
70. IVANCEV K., LUNDERQUIST A., ISAKSSON A., HOCHBERGS P. & WRETLIND A.: Clinical trials with a new lipid emulsion for computed tomography of the liver. Acta Radiol. 30 (1989), 449.
71. IVANCEV K., LUNDERQUIST A., MCCUSKEY R., MCCUSKEY P. & WRETLIND A.: Effect of intravenously injected iodinated lipid emulsions on the liver. Acta Radiol. 30 (1989), 291.
72. IVANCEV K., LUNDERQUIST A., MCCUSKEY R., MCCUSKEY P. & WRETLIND A.: Experimental investigation of a new iodinated lipid emulsion for computed tomography of the liver. Acta Radiol. 30 (1989), 407.
73. JENSEN D., CHAIKOFF I. & TRAVER H.: The ethionine-induced fatty liver. Dosage, prevention, and structural specificity. J. Biol. Chem. 192 (1951), 395.
74. KNOL J., MARN C., FRANCIS I., RUBIN J., BROMBERG J. & CHANG A.: Comparisons of dynamic infusion and delayed computed tomography, intraoperative ultrasound, and palpation in the diagnosis of liver metastases. Am. J. Surg. 165 (1993), 81.
75. KOUNTOURAS J., BILLING B. & SCHEUER P.: Prolonged bile duct obstruction. A new experimental model of cirrhosis in the rat. Br. J. Exp. Pathol. 65 (1984), 305.
76. KRAHENBUHL S. & BRASS E.: Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis. Hepatology 14 (1991), 927.
77. KREFT B., TANIMOTO A., BABA Y. et al.: Diagnosis of fatty liver with MR imaging. J. Magn. Reson. Imaging 2 (1992), 463.
78. KREFT B., TANIMOTO A., BABA Y., ZHAO L., FINN J. & STARK D: Enhanced tumor detection in the presence of fatty liver disease. Cell-specific contrast agents. J. Magn. Reson. Imaging 4 (1994), 337.
79. KRÄHENBUHL S., TALOS C., LAUTERBURG B. & REICHEN J.: Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 22 (1995), 607.
80. KRÄHENBUHL S., TALOS C. & REICHEN J.: Mechanisms of impaired hepatic fatty acid metabolism in rats with long-term bile duct ligation. Hepatology 19 (1994), 1272.
81. KUSZYK B. S., BLUEMKE D, URBAN B. et al.: Portalphase contrast-enhanced helical CT for the detection of malignant hepatic tumors. Sensitivity based on comparison with intraoperative and pathologic findings. AJR 166 (1996), 91.
82. LAMARQUE J., BRUEL J., DONDELINGER R., VENDRELL B. et al.: The use of iodolipids in hepatosplenic computed tomography. J. Comput. Assist. Tomogr. 3 (1979), 21.
83. LAUTEALA L., KORMANO M. & VIOLANTE M.: Uptake and dissolution of particulate iodipamide ethyl ester in the spleen. A morphologic study. Invest. Radiol. 22 (1987), 829.
84. LAVAL-JEANTET M., LAMARQUE J., DREUX P., LAVAL-JEANTET A. & LAUNAY J.: Hepatosplenography by intravenous injection of new iodized oily emulsion. Acta Radiol. Diagn. 17 (1976), 49.
85. LEANDER P.: A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumour model. Acta Radiol. 37 (1996), 63.
86. LEANDER P., GOLMAN K., STRANDE P., KLAVENESS J., BESJAKOV J. & FÄLT K.: A comparison between IEEC, a new biodegradable particulate contrast medium, and iohexhol in a tumor model of computed tomography imaging of the liver. Invest. Radiol. 28 (1993), 513.
87. LEE F. T. JR, SPROAT I. A., RAPPE A. H., VIOLANTE M. R. & BRONSON J. P.: Liver enhancement techniques in computed tomography. A comparison of intravenous bolus, computed tomographic portography, and iodipamide ethyl ester particle injections in a canine model. Invest. Radiol. 29 Suppl. 2 (1994), S289.
88. LEEN E., ANGERSON W., WOTHERSPOON H., MOULE B., COOK T. & MCARDLE C.: Detection of colorectal liver metastases. Comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology 195 (1995), 113.
89. LUNDSTEDT C., EKBERG H., HEDERSTRÖM E., STRIDBECK H., TORFASON B. & TRANBERG K.-G.: Radiologic diagnosis of liver metastases in colo-rectal carcinoma. Acta Radiol. 28 (1987), 431.
90. MAHFOUZ A.-E., HAMM B. & MATHIEU D.: Imaging of metastases to the liver. Eur. Radiol. 6 (1996), 607.
91. MARCHAL G. & BAERT A. L.: Dynamic CT of the liver. Radiologe 32 (1992), 211.
92. MATSUI O., KADOYA M., KAMEYAMA T. et al.: Benign and malignant nodules in cirrhotic livers. Distinction based on blood supply. Radiology 178 (1991), 493.
93. MATSUI Q., TAKASHIMA T., KADOYA M. et al.: Liver metastases from colorectal cancers. Detection with CT during arterial portography. Radiology 165 (1987), 65.
94. MATTREY R.: Perfluorooctylbromide. A new contrast agent for CT, sonography, and MR imaging. AJR 152 (1989), 247.
95. MATTREY R.: Potential role of perfluorooctylbromide in the detection and characterization of liver lesions with CT. Radiology 170 (1989), 18.
96. MATTREY R. F. & SHELTON R. E.: Perfluorocarbon emulsions in diagnostic imaging. An overview and some experimental considerations. In: Contrast media. Biologic effects and clinical application, p. 105. Edited by Z. Parvez, R. Montana and M. Sovak, CRC Press, Boca Raton 1987.
97. MAZZAFERRO V., REGALIA E., DOCI R. et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Engl. J. Med. 334 (1996), 693.
98. MCGRATH P., MALONE D., DOBRANOWSKI J., GILL G., SOMERS S. & STEVENSON G.: Same-day computed tomography during arterial portography and delayed high-iodine computed tomography. An efficient approach to imaging potentially resectable liver tumours. Can. Assoc. Radiol. J. 44 (1993), 262.
99. MERINE D., TAKAYASHU K. & WAKAO F.: Detection of hepatocellular carcinoma. Comparison of CT during arterial portography with CT after intra-arterial injection of iodized oil. Radiology 175 (1990), 707.
100. MILLER D., O'LEARY T., VUCICH J., GIRTON M., VERMESS M. & DOPPMAN J.: Experimental evaluation of five liver-spleen specific CT contrast agents. J. Cornput. Assist. Tomogr. 7 (1983), 1022.
101. MILLER D., VERMESS M., DOPPMAN J. et al: CT of the liver and spleen with EOE-13. Review of 225 examinations. AJR 143 (1984), 235.
102. MILLER D. L., SIMMONS J. T., CHANU R. et al.: Hepatic metastasis detection. Comparison of three CT contrast enhancement methods. Radiology 165 (1987), 785.
103. MILLER W., FEDERLE M. & CAMPBELL W.: Diagnosis and staging of hepatocellular carcinoma. Comparison of CT and sonography in 36 liver transplantation patients. AJR 157 (1991), 303.
104. MILLER W. J., BARON R. L., DODD G. D. III & FEDERLE M. P.: Malignancies in patients with cirrhosis. CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193 (1994), 645.
105. MITSUZAKI K., YAMASHITA Y., OGATA I., NISHIHARU T., URATA J. & TAKAHASHI M.: Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis. Contrast-injection protocol and optimal timing. AJR 167 (1996), 753.
106. MORRIS T.: X-ray contrast media. Where are we now, and where are we going? Radiology 188 (1993), 11.
107. MORROW C., GRACE T., SUTHERLAND D. & NAJARIAN J.: Hepatic resection for secondary neoplasms. Surgery 92 (1982), 610.
108. MüHLER A., PREISE C., KUWATSURU R. et al.: Acute liver rejection. Evaluation with cell-directed MR contrast agents in a rat transplantation model. Radiology 186 (1993), 139.
109. NAZARIAN L., WECHSLER R., GRADY C. et al.: CT done 4-6 hr after CT arterial portography. Value in detecting hepatic tumors and differentiating from other hepatic perfusion defects. AJR 163 (1994), 851.
110. NELSON R. C., CHEZMAR J. L., SUGARBAKER P. H. & BERNARDINO M. E.: Hepatic tumors. Comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 172 (1989), 27.
111. Ni Y., MARCHAL G., Yu J. et al.: Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors. Comparison of magnetic resonance imaging, microangiographic, and histologic findings. Acad. Radiol. 2 (1995), 687.
112. NOMURA F., OHNISHI K., OCHIAI T. & OKUDA K.: Obesity-related nonalcoholic fatty liver. CT features and follow-up studies after low-calorie diet. Radiology 162 (1987), 845.
113. OHASHI I., HANAFUSA K. & YOSHIDA T.: Small hepatocellular carcinomas. Two-phase dynamic incremental CT in detection and evaluation. Radiology 189 (1993), 851.
114. OHTOMO K., BARON R., DODD G. III et al.: Confluent hepatic fibrosis in advanced cirrhosis. Appearance at CT. Radiology 188 (1993), 31.
115. OKUDA K.: Hepatocellular carcinoma. Recent progress. Hepatology 15 (1992), 948.
116. OLIVER J. III & BARON R.: Helical biphasic contrastenhanced CT of the liver. Technique, indications, interpretation, and pitfalls. Radiology 201 (1996), 1.
117. OLIVER J. III, BARON R., DODD G. III, PETERSON M. & CARR B.: Does advanced cirrhosis with portosystemic shunting affect the value of CT arterial portography in evaluation of the liver? AJR 164 (1995), 333.
118. ÖHMAN U.: Colorectal cancer. A survey of 1345 cases 1950-1984. Acta Chir. Scand. 151 (1985), 675.
119. PANIS Y., NORDLINGER B., DELELO R. et al.: Experimental colorectal liver metastases. Influence of sex, immunological status and liver regeneration. J. Hepatol. 11 (1990), 53.
120. PARTANEN K., PIKKARAINEN P., PASANEN P., ALHAVA E. & SOIMAKALLIO S.: Ultrasonography and computed tomography in diffuse liver disease with cholestasis. Acta Radiol. 31 (1990), 477.
121. PAUSHTER D., ZEMAN R., SCHEIBLER M., CHOYKE P., JAFFE M. & CLARK L.: CT evaluation of suspected hepatic metastases. Comparison of techniques for iv contrast enhancement. AJR 152 (1989), 267.
122. PETERSON M., BARON R., DODD G. III et al.: Hepatic parenchymal perfusion defects detected with CTAP. Imaging-pathologic correlation. Radiology 185 (1992), 149.
123. PLAA G.: Toxic responses of the liver. In: Casarett and Doull's toxicology. The basic science of poisons. Edited by C. Klaassen, M. Amdur & J. Doull. Macmillan Publishing Co., New York 1986.
124. PUDDU P., CALDARERA C. & MARCHETTI M.: Studies on ethionine-induced fatty liver. Biochem. J. 102 (1967), 163.
125. QIN Y., KOEN D. & WILLEMS G.: Easy production and early detection of liver metastases of colon cancer in rats. Surg. Res. Comm. 9 (1990), 99.
126. REIMER P., WEISSLEDER R., NICKELEIT V & BRADY T.: Animal models for magnetic resonance imaging research of the liver. Invest. Radiol. 27 (1992), 390.
127. RESNIK R. H. & KOFF R.: Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch. Intern. Med. 153 (1993), 1672.
128. ROFSKY N. & FLEISHAKER H.: CT and MRI of diffuse liver disease. Semin. Ultrasound CT MRI 16 (1995), 16.
129. ROSEN B., CARTER E., PYKETT I., BUCHBINDER B. & BRADY T.; Proton chemical shift imaging. An evaluation of its clinical potential using an in vivo fatty liver model. Radiology 154 (1985), 469.
130. RUBIN D., DESSER T., QING F. et al.: Nanoparticulate contrast media. Blood-pool and liver-spleen imaging. Invest. Radiol. 29 (1994), S280.
131. SAINI S., STARK D., WITTENBERG J., Vici L.-G., BROWN A. & FERRUCI J.: A rat model of liver cancer for imaging research. Invest. Radiol. 22 (1987), 149.
132. SCHLUNK F. & LOMBARDI B.: On the ethionine-induced fatty liver in male and female rats. Lab. Invest. 17 (1967), 299.
133. SCHMIEDL U., KRAUSE W., LEIKE J., NELSON J. & SCHUMANN-GIAMPIERI G.: Liver contrast enhancement in primates using iopromide liposomes. Acad. Radiol. 2 (1995), 967.
134. SELTZER S.: Contrast-carrying liposomes. Current status. Invest. Radiol. 23 (1988), S122.
135. SELTZER S.: The role of liposomes in diagnostic imaging. Radiology 171 (1989), 19.
136. SELTZER S., ADAMS D., DAVIS M. et al.: Hepatic contrast agents for computed tomography. High atomic number paniculate material. J. Comput. Assist. Tomogr. 5 (1981), 370.
137. SELTZER S., BLAU M., HERMAN L. et al.: Contrast material-carrying liposomes. Biodistribution, clearance, and imaging characteristics. Radiology 194 (1995), 775.
138. SHARKEY F. & FOGH J.: Considerations in the use of nude mice for cancer research. Cancer Met. Rev. 3 (1984), 341.
139. SHIRKHODA A. & BAIRD S.: Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma. CT findings. Abdom. Imaging 19 (1994), 39.
140. SILVERMAN P., COOPER C. & ZEMAN R.: Imaging of the liver. A survey update of prevailing techniques for conventional CT scanning. Abdom. Imaging 20 (1995), 348.
141. SILVERMAN P. M., O'MALLEY J., TEFFT M. C., COOPER C. & ZEMAN R. K.: Conspicuity of hepatic metastases on helical CT. Effect of different time delays between contrast administration and scanning. AJR 164 (1995), 619.
142. SIMONETTI R. G., CAMMÀ C., FIORELLO F., POLITI F., D'AMiCO G. & PAGLIARO L.: Hepatocellular carcinoma. A worldwide problem and the major risk factor. Dig. Dis. Sci. 36 (1991), 962.
143. SMALL W. C., NELSON R. C., BERNARDINO M. E. & BRUMMER L. T.: Contrast-enhanced spiral CT of the liver. Effect of different amounts and injection rates of contrast material on early contrast enhancement [see comments]. AJR 163 (1994), 87.
144. SOYER P., BLUEMKE D., HRUBAN R., SITZMAN J. & FISHMAN E.: Hepatic metastases from colorectal cancer. Detection and false-positive findings with helical CT during arterial portography. Radiology 193 (1994), 71.
145. SOYER P., BLUEMKE D. HRUBAN R., SITZMANN J. & FISHMAN E.: Primary malignant neoplasms of the liver. Detection with helical CT during arterial portography. Radiology 192 (1994), 389.
146. SOYER P., BLUEMKE D., ZEITOUN G., MARMUSE J.-P & LEVESQUE M.: Detection of recurrent hepatic metastases after partial hepatectomy. AJR 162 (1993), 1327.
147. SOYER P., LACHEHEB D. & LEVESQUE M.: False-positive CT portography. Correlation with pathologic findings. AJR 160 (1993), 285.
148. SOYER P., LAISSY J.-P., SIBERT A. et al.: Focal hepatic masses. Comparison of detection during arterial portography with MR imaging and CT. Radiology 190 (1994), 737.
149. SOYER P., LEVESQUE M., ELIAS D., ZEITOUN G. & ROCHE A.: Preoperative assessment of resectability of hepatic metastases from colonic carcinoma. CT portography vs sonography and dynamic CT. AJR 159 (1992), 741.
150. STEVENS R., JOHNSON C., STEPHENS D. & BATTS K.: CT findings in hepatocellular carcinoma. Correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology 191 (1994), 531.
151. SUGARBAKER P.: Surgical decision making for large bowel cancer metastatic to the liver. Radiology 174 (1990), 621.
152. SUGARBAKER P., VERMESS M., DOPPMAN J., MILLER D. & SIMON R.: Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion (EOE-13) liver contrast. Cancer 54 (1984), 1489.
153. SUNDIN A., AHLSTRÖM H., GRAF W. & MAGNUSSON A.: Computed tomography of experimental liver metastases using an iodinated hepatocyte-specific lipid emulsion. A correlative study in the nude rat. Invest. Radiol. 29 (1994), 963.
154. SUNDIN A., GRAF W., GLIMELIUS B., AHLSTRÖM H. & MAGNUSSON A.: Contrast-enhanced CT scanning in vivo for the quantification of hepatic metastases from a human colonic cancer in the nude rat. Eur. J. Surg. Oncol. 18 (1992), 615.
155. TAKAYASU K., FURUKAWA H., WAKAO F. et al.: CT diagnosis of early hepatocellular carcinoma. Sensitivity, findings, and CT-pathologic correlation. AJR 164 (1995), 885.
156. TAKAYASU K., MORIYAMA N., MURAMATSU Y. et al.: The diagnosis of small hepatocellular carcinomas. Efficacy of various imaging procedures in 100 patients. AJR 155 (1990), 49.
157. TAKAYASU K., MURAMATSU Y., FURUKAWA H. et al.: Early hepatocellular carcinoma. Appearance at CT during arterial portography and CT arteriography with pathologic correlation. Radiology 194 (1995), 101.
158. TAOUREL P., PAGEAUX G., COSTE V. et al.: Small hepatocellular carcinoma in patients undergoing liver transplantation. Detection with CT after injection of iodized oil. Radiology 197 (1995), 377.
159. TAYLOR A., CARMODY T., QUIROZ F. et al: Focal masses in cirrhotic liver. CT and MR imaging features. AJR 163 (1994), 857.
160. TESSITORE L., SESCA E., GRECO M., PANI P. & DIANZANI M.: Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int. J. Exp. Pathol. 76 (1995), 125.
161. THOMAS S.: Hepatolienography ten years later. Radiology 78 (1962), 435.
162. TIDEBRANT G., ASZTELY M., LUKES P. & TYLÉN U.: Comparison of non-enhanced, bolus enhanced, and delayed scanning techniques in computed tomography of hepatic tumours. Acta Radiol. 31 (1990), 161.
163. TIDEBRANT G., HAFSTRÖM L. & TYLÉN U.: Evaluation of intrahepatic tumour extent and prediction of resection size in liver tumours by computed tomography, ultrasonography and angiography. Acta Radiol. 30 (1989), 395.
164. VERMESS M., CHATTERJI D., DOPPMAN J., GRIMES G. & ADAMSON R.: Development and experimental evaluation of a contrast medium for computed tomographic examination of the liver and spleen. J. Cornput. Assist. Tomogr. 3 (1979), 25.
165. VERMESS M., DOPPMAN J., SUGARBAKER P. et al.: Clinical trials with a new intravenous liposoluble contrast material for computed tomography of the liver and spleen. Radiology 137 (1980), 217.
166. VERMESS M., DOPPMAN J., SUGARBAKER P. et al.: Computed tomography of the liver and spleen with intravenous lipoid contrast material. Review of 60 examinations. AJR 138 (1982), 1063.
167. VIOLANTE M. R. & FISHER H. W: Efficacy and safety of IDE particulate suspension for liver CT enhancement. In: Contrast media. Biologic effects and clinical application, p. 89. Edited by Z. Parvez, R. Montana and M. Sovak, CRC Press, Boca Raton 1987.
168. WALKEY M.: Dynamic hepatic CT. How many years will it take 'til we learn? Radiology 181 (1991), 17.
169. WEICHERT J., LONGINO M., BAKAN D. et al.: Targeted polyiodinated triglycerides for hepatic computed tomography. Invest. Radiol. 29 (1994), S284.
170. WEICHERT J., LONGINO M., SPIGARELLI M., LEE F., SCHWENDNER S. & COUNSELL R.: Computed tomography scanning of Morris hepatomas with liver-specific polyiodinated triglycerides. Acad. Radiol. 3 (1996), 412.
171. WRETLIND A.: Development of fat emulsions. J. Parent. Ent. Nutr. 5 (1981), 230.
172. YAMASHITA Y., MITSUZAKI K., YI T. et al.: Small hepatocellular carcinoma in patients with chronic liver damage. Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200 (1996), 79.